Understanding SARS-CoV-2-Mediated Inflammatory Responses: From

Currently there is no effective antiviral therapy for SARS-CoV-2 infection, which frequently leads to fatal inflammatory responses and acute lung injury. Here, we discuss the various mechanisms of SARS-CoV-mediated inflammation. We also assume that SARS-CoV-2 likely shares similar inflammatory responses. Potential therapeutic tools to reduce SARS-CoV-2-induced inflammatory responses include various methods to block FcR activation. In the absence of a proven clinical FcR blocker, the use of intravenous immunoglobulin to block FcR activation may be a viable option for the urgent treatment of pulmonary inflammation to prevent severe lung injury. Such treatment may also be combined with systemic anti-inflammatory drugs or corticosteroids. However, these strategies, as proposed here, remain to be clinically tested for effectiveness.

Frontiers Cellular and Molecular Pathways of COVID-19 and Potential Points of Therapeutic Intervention

Impaired local intrinsic immunity to SARS-CoV-2 infection in severe COVID-19 - ScienceDirect

Eje Renina Angiotensina, Enzima Convertidora de Angiotensina 2 y Coronavirus

SARS-CoV-2 mediated lung inflammatory responses in host: targeting the cytokine storm for therapeutic interventions

COVID-19 therapeutics: Challenges and directions for the future

COVID-19 infection: an overview on cytokine storm and related interventions, Virology Journal

COVID-19 Vaccines in Patients with Immune-Mediated Inflammatory Diseases – Consult QD

Post-acute sequelae of COVID-19: understanding and addressing the burden of multisystem manifestations - The Lancet Respiratory Medicine

Tobacco product use and the risks of SARS-CoV-2 infection and COVID-19: current understanding and recommendations for future research - The Lancet Respiratory Medicine

SARS-CoV-2 and innate immunity: the good, the bad, and the “goldilocks”

COVID-19: Locked in a pro-inflammatory state

COVID-19: inflammatory responses, structure-based drug design and potential therapeutics

Understanding SARS-CoV-2 and the drugs that might lessen its power

Viruses, Free Full-Text